Transaction #3150 · Form 4 · 0001907345-25-000005
Lyell Immunopharma, Inc. · Stock award · Option (right to buy)
Lyell Immunopharma, Inc. · Transacted October 27, 2025 · Filed October 29, 2025
What does this filing report?
An SEC Form 4 filing for Lyell Immunopharma, Inc. records a stock award involving Option (right to buy) on October 27, 2025. The reported quantity was 68,000. The filing date is October 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Lyell Immunopharma, Inc.
- Company CIK
- 0001806952
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 68,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 68,000
- Ownership description
- Not reported
- SEC acceptance time
- Oct 29, 2025, 5:41 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Lee Gary K. ↗
Chief Scientific Officer
CIK 0001907345
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 68,000
- Conversion / exercise price
- 17.23
- Exercise date
- Not reported
- Expiration date
- October 26, 2035
Filing footnotes & remarks
- F1
- 12.5% of the option shares will vest on April 27, 2026, with the remaining option shares to vest in equal monthly installments over the following forty-two months, subject to the reporting person providing service through the applicable vesting date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.